Theo Brandt-Sarif

Consultant Physician @Gilead Sciences

Los Angeles, CA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Aug 2010 — Present

Consultant Physician @Gilead Sciences

View department →

Foster City, CA, US

Respiratory: Assisted medical monitor, rescuing study assessing Ambrisentan in IPF. Focused on increasing accrual including protocol revision and site visits.•Cardiovascular: To speed up enrollment, expanded clinical sites within Europe for Ranolazine SPECT-MPI mechanism of action study in IHD.•Cardiovascular: Implemented plan to rapidly boost enrollment into RIVER PCI study with Ranolazine.•Oncology: Implemented plan to rapidly boost enrollment into pivotal Phase 3 study with Idelalisib for CLL.•HCV: Medical monitor for end stage liver disease program assessing Sovaldi and Harvoni, covering approximately 20 protocols.•Oncology: Medical monitor for CLL Idelalisib extension study.•HCV: Responsible for assessing global Compassionate Use requests for Sovaldi.•Oncology: Medical monitor for gastric cancer protocol assessing MMP9 compound GS-5745. Performed site visits to accelerate study enrollment.•HIV: Contributed safety sections for Truvada NDA.

EDUCATION

1976 — 1982

University of the Witwatersrand

MD, Medicine

1984 — 1986

The Wharton School

MBA, Health Care Management

SKILLS

Clinical SupervisionMycologyClinicalMedical WritingClinical TrialsAntibioticsManagement ConsultingStrategyPharmaceuticalsSafety ManagementIndPharmacovigilanceRegulatory AffairsSafetyClinical Trial ManagementConsultancyRespiratory TherapyClinical OperationsClnical TrialsEndocrinologyClinical DevelopmentPhysiciansInfectious DiseasesAnti-InfectivesNeurologyRegulatory StrategyMedical AffairsBiotechnologyCROClinical ResearchPharmaceutical IndustryFdaDrug SafetyDrug DevelopmentGcpBiopharmaceuticalsTherapeutic AreasMedicineCtmsRegulatory Submissions

ABOUT THEO BRANDT-SARIF

Seasoned pharmaceutical consultant with a demonstrated history of accelerating patient accrual into clinical trials that are lagging their enrollment goals.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.